Table 2.
Patient | Total doses received | Max dose received | Number of maximum doses received | Dose reduction | Treatment discontinued | Reason |
---|---|---|---|---|---|---|
1 | 24 | 1.2 | 14 | No | No | |
2 | 12 | 1.2 | 5 | Yes | Yes | Disease progression |
3 | 9 | 1.2 | 3 | No | Yes | Disease progression |
4 | 6 | 1 | 2 | No | Yes | Nausea/vomiting |
5 | 1 | 0.6 | 1 | No | Yes | EF-15% |
6 | 10 | 1.2 | 4 | No | Yes | Fatigue |
7 | 5 | 1 | 1 | No | Yes | Disease progression |
8 | 24 | 1.2 | 18 | No | No | |
9 | 12 | 1.2 | 6 | No | Yes | Disease progression |
10 | 37 | 1.2 | 31 | No | During second course | Anorexia, nausea/vomiting |
11 | 24 | 1.2 | 2 | Yes | No | |
12 | 2 | 0.6 | 2 | No | Yes | Non-ST elevated MI |
13 | 14 | 1.2 | 8 | No | Yes | Disease progression |
14 | 0 | DOD before first dose |
DOD dead of disease